Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Medicenna Therapeutics Q1 EPS $(0.07) Misses $(0.06) Estimate

Medicenna Therapeutics (NASDAQ:MDNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 30 percent increase over losses of $(0.10) per share
byBenzinga Newsdesk
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Medicenna Therapeutics (NASDAQ:MDNA) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 30 percent increase over losses of $(0.10) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview For Welltower

By Benzinga Insights
February 14, 1:05 PM
Welltower (NYSE:WELL) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that Welltower will report an earnings per share (EPS) of $0.15.

WELL